Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression

Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression

Background: Nucleos(t)ide analog (NA) treatment for hepatitis B virus (HBV) infection may improve clinically significant portal hypertension (CSPH). Data on hepatic venous pressure gradient (HVPG) and non-invasive tests (NITs) for risk re-stratification in virally suppressed HBV-infected patients wi...

Full description

Bibliographic Details
Main Authors: Mathias Jachs, Lukas Hartl, David Bauer, Benedikt Simbrunner, Albert Friedrich Stättermayer, Robert Strassl, Michael Trauner, Mattias Mandorfer, Thomas Reiberger
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Personalized Medicine
Subjects:
cirrhosis
portal hypertension
antivirals
nucleos(t)ide analogs
disease regression
transient elastography
Online Access:https://www.mdpi.com/2075-4426/12/2/239

Similar Items

Similar Items